| 1 |
32335549 | MicroRNA-93 Targets p21 and Promotes Proliferation in Mycosis Fungoides T Cells. | 2021 |
1 |
| 2 |
34066975 | Effect of the HDAC Inhibitor on Histone Acetylation and Methyltransferases in A2780 Ovarian Cancer Cells. | 2021 May 7 |
2 |
| 3 |
32878786 | CDKN1A Gene Expression in Two Multiple Myeloma Cell Lines With Different P53 Functionality. | 2020 Sep |
1 |
| 4 |
30307360 | The histone deacetylase inhibitor Suberoylanilide Hydroxamic Acid (SAHA) as a therapeutic agent in rhabdomyosarcoma. | 2019 |
2 |
| 5 |
27926517 | Suberoylanilide hydroxamic acid-induced specific epigenetic regulation controls Leptin-induced proliferation of breast cancer cell lines. | 2017 Jan 10 |
2 |
| 6 |
28123594 | Histone Deacetylase Inhibitor SAHA as Potential Targeted Therapy Agent for Larynx Cancer Cells. | 2017 |
2 |
| 7 |
27697993 | Retraction: Synergistic Interactions between Vorinostat and Sorafenib in Chronic Myelogenous Leukemia Cells Involve Mcl-1 and p21CIP1 Down-Regulation. | 2016 Oct 1 |
1 |
| 8 |
26178881 | Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy. | 2015 Jul 16 |
3 |
| 9 |
26506264 | p21(WAF1) modulates drug-induced apoptosis and cell cycle arrest in B-cell precursor acute lymphoblastic leukemia. | 2015 |
6 |
| 10 |
24639460 | P21-driven multifusion gene system for evaluating the efficacy of histone deacetylase inhibitors by in vivo molecular imaging and for transcription targeting therapy of cancer mediated by histone deacetylase inhibitor. | 2014 Apr |
2 |
| 11 |
24686006 | Superior activity of a new histone deacetylase inhibitor (ZYJ-34c) in inhibiting growth of human leukemia cells by inducing p21WAF1 expression and cell cycle arrest. | 2014 Aug |
1 |
| 12 |
24886166 | Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells. | 2014 May 27 |
1 |
| 13 |
23515411 | A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2. | 2013 Apr 1 |
1 |
| 14 |
23536727 | Expression of leukemia-associated fusion proteins increases sensitivity to histone deacetylase inhibitor-induced DNA damage and apoptosis. | 2013 Aug |
2 |
| 15 |
21598070 | Vorinostat modulates cell cycle regulatory proteins in glioma cells and human glioma slice cultures. | 2011 Nov |
1 |
| 16 |
21903579 | p53-independent epigenetic repression of the p21(WAF1) gene in T-cell acute lymphoblastic leukemia. | 2011 Oct 28 |
2 |
| 17 |
21931726 | The mechanism of action of the histone deacetylase inhibitor vorinostat involves interaction with the insulin-like growth factor signaling pathway. | 2011 |
2 |
| 18 |
19875160 | Suberoylanilide hydroxamic acid (SAHA) potentiates paclitaxel-induced apoptosis in ovarian cancer cell lines. | 2010 Jan |
2 |
| 19 |
20202195 | Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo. | 2010 Mar 4 |
2 |
| 20 |
20384633 | Histone deacetylase inhibitor enhances sensitivity of non-small-cell lung cancer cells to 5-FU/S-1 via down-regulation of thymidylate synthase expression and up-regulation of p21(waf1/cip1) expression. | 2010 Jun |
1 |
| 21 |
20846458 | Suberoylanilide hydroxamic acid induces apoptosis and sub-G1 arrest of 320 HSR colon cancer cells. | 2010 Sep 17 |
1 |
| 22 |
19330811 | Variations in c-Myc and p21WAF1 expression protect normal peripheral blood lymphocytes against BimEL-mediated cell death. | 2009 Apr |
4 |
| 23 |
18850582 | SAHA induces caspase-independent, autophagic cell death of endometrial stromal sarcoma cells by influencing the mTOR pathway. | 2008 Dec |
4 |
| 24 |
17417771 | Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells. | 2007 Aug 1 |
2 |
| 25 |
17499001 | HDAC inhibitors induce apoptosis in glucocorticoid-resistant acute lymphatic leukemia cells despite a switch from the extrinsic to the intrinsic death pathway. | 2007 |
3 |
| 26 |
17634558 | Synergistic interactions between vorinostat and sorafenib in chronic myelogenous leukemia cells involve Mcl-1 and p21CIP1 down-regulation. | 2007 Jul 15 |
7 |
| 27 |
17638911 | Histone deacetylase inhibitors enhance lexatumumab-induced apoptosis via a p21Cip1-dependent decrease in survivin levels. | 2007 Jul 15 |
1 |
| 28 |
16015388 | Synergistic interactions between MEK1/2 and histone deacetylase inhibitors in BCR/ABL+ human leukemia cells. | 2005 Sep |
1 |
| 29 |
16144943 | Activity of suberoylanilide hydroxamic Acid against human breast cancer cells with amplification of her-2. | 2005 Sep 1 |
2 |
| 30 |
16297208 | Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. | 2005 Nov |
4 |
| 31 |
14734806 | Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. | 2004 Feb 3 |
6 |
| 32 |
12727828 | Histone deacetylase inhibitors promote STI571-mediated apoptosis in STI571-sensitive and -resistant Bcr/Abl+ human myeloid leukemia cells. | 2003 May 1 |
2 |
| 33 |
12893773 | The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571. | 2003 Nov 15 |
1 |
| 34 |
14614324 | Induction of apoptosis in BCR/ABL+ cells by histone deacetylase inhibitors involves reciprocal effects on the RAF/MEK/ERK and JNK pathways. | 2003 Sep-Oct |
1 |
| 35 |
14654560 | Histone deacetylase inhibitors induce growth suppression and cell death in human rhabdomyosarcoma in vitro. | 2003 Nov 15 |
2 |
| 36 |
14679005 | Coadministration of the heat shock protein 90 antagonist 17-allylamino- 17-demethoxygeldanamycin with suberoylanilide hydroxamic acid or sodium butyrate synergistically induces apoptosis in human leukemia cells. | 2003 Dec 1 |
3 |
| 37 |
11831887 | Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates. | 2002 Feb 14 |
3 |
| 38 |
12094258 | Synergistic induction of mitochondrial damage and apoptosis in human leukemia cells by flavopiridol and the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA). | 2002 Jul |
2 |
| 39 |
10954755 | Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. | 2000 Aug 29 |
6 |
| 40 |
11126200 | Suberoylanilide hydroxamic acid as a potential therapeutic agent for human breast cancer treatment. | 2000 Oct |
1 |
| 41 |
11126357 | Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites. | 2000 Nov 23 |
7 |
| 42 |
10597302 | Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53. | 1999 Nov 25 |
4 |